Spineway SAS (ALSPW):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Spineway SAS (ALSPW) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7343
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:34
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フランス
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Spineway SAS (Spineway) is a medical device company that manufactures, designs, and commercializes surgical implants and instruments. The company offers products such as thoraco-lumbar, cervical, mini invasive products and other bio materials. Its thoraco-lumbar products include mont blanc degenerative, mont blanc deformity, mont blanc baby, twin peaks and kili and cervical products comprise ayers rock and blue mountain. Spineway also provides mini invasive surgical instrument rift; and other bio-materials such as neve and sonora. The company serves adults and infants suffering from spinal injury. The company markets spinal implants and surgical instruments throughout the world for treating spinal disorders such as scoliosis. Spineway is headquartered in Lyon, France.

Spineway SAS (ALSPW) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Spineway SAS, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Spineway SAS, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Spineway SAS, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Spineway SAS, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Spineway SAS, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Spineway SAS, Medical Equipment, Deal Details 10
Private Equity 10
Spineway to Raise up to USD11.8 Million in Private Placement of Bonds and Warrants 10
Partnerships 11
Spineway Enters into Distribution Agreement 11
Tinavi Medical Technology Enters into Distribution Agreement with Spineway 12
Equity Offering 13
Spineway Raises USD1.68 Million in Private Placement of Shares 13
Spineway Completes Private Placement Of Shares For US$6.6 Million 14
Debt Offering 15
Spineway Raises Funds through First Tranche of Private Placement of Notes and Warrants 15
Spineway SAS – Key Competitors 16
Spineway SAS – Key Employees 17
Spineway SAS – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Recent Developments 19
Financial Announcements 19
Jul 11, 2018: SPINEWAY: Revenue for the first half of 2018 19
Apr 26, 2018: Spineway: 2017 Annual Results and Activity for the First Quarter 2018 20
Jan 17, 2018: SPINEWAY : 2017 was an historic year: EUR9.1M (+97%) 21
Oct 23, 2017: SPINEWAY: 1st Half of 2017 – nine-month sales revenue of €7.4M (+125%) 22
Jul 18, 2017: Spineway: Confirmed growth Revenue for the first half of 2017: €6M (+146%) 24
Apr 26, 2017: Spineway: 2016 Annual results 25
Corporate Communications 26
Nov 07, 2017: Joseph Brigneaud nominated to Spineway’s Board of Directors 26
Product News 27
Sep 27, 2018: Spineway: Presentation of its new Mont-Blanc Evo line at the Eurospine 2018 conference 27
Other Significant Developments 28
Nov 22, 2017: Spineway: Implementation Of The Skyway 2018 Plan 28
Jun 14, 2017: Spineway Records a New $1M Order in the USA 29
Apr 05, 2017: Spineway: Signature of a distribution agreement in Australia 1st Mont-Blanc implants 30
Mar 01, 2017: Spineway: New distribution contract in the USA; Appointment of Philippe Laurito as head of the US subsidiary 31
Jan 19, 2017: Spineway: 2016 sales revenue
Jan 10, 2017: Spineway: Signature of a new distribution agreement in the US 33
Appendix 34
Methodology 34
About GlobalData 34
Contact Us 34
Disclaimer 34

List of Tables
Spineway SAS, Medical Equipment, Key Facts, 2017 2
Spineway SAS, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Spineway SAS, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Spineway SAS, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Spineway SAS, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Spineway SAS, Deals By Market, 2012 to YTD 2018 8
Spineway SAS, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Spineway to Raise up to USD11.8 Million in Private Placement of Bonds and Warrants 10
Spineway Enters into Distribution Agreement 11
Tinavi Medical Technology Enters into Distribution Agreement with Spineway 12
Spineway Raises USD1.68 Million in Private Placement of Shares 13
Spineway Completes Private Placement Of Shares For US$6.6 Million 14
Spineway Raises Funds through First Tranche of Private Placement of Notes and Warrants 15
Spineway SAS, Key Competitors 16
Spineway SAS, Key Employees 17
Spineway SAS, Subsidiaries 18

List of Figures
Spineway SAS, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Spineway SAS, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Spineway SAS, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Spineway SAS, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Spineway SAS, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Spineway SAS, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Spineway SAS, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Spineway SAS, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Spineway SAS (ALSPW):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Eureka Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Eureka Therapeutics Inc (Eureka Therapeutics) is a clinical stage biotechnology company which focuses on the development of novel T cell immunotherapies for the treatment of solid tumors. Its pipeline encompasses drug candidates for various indications such as liver cancer, hematological can …
  • McCarthy Building Companies Inc:企業の戦略的SWOT分析
    McCarthy Building Companies Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro …
  • Homology Medicines, Inc. (FIXX):製薬・医療:M&Aディール及び事業提携情報
    Summary Homology Medicines, Inc. (Homology Medicines) is a pre-clinical stage biopharmaceutical company engaged in translating gene editing and gene therapy into novel treatment for patients suffering from rare genetic diseases. It offers HMI-102 product, which is in clinical stage for the treatment …
  • ConSynance Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary ConSynance Therapeutics Inc (ConSynance Therapeutics), formerly Concerted Therapeutics Inc is a drug discovery company that concentrates on the development of new therapeutic solutions for unmet medical needs. The company provides pipeline programs such as CSTI-100, CSTI-200, and CSTI-300, a …
  • ConocoPhillips (COP):企業の財務・戦略的SWOT分析
    ConocoPhillips (COP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Sempra U.S. Gas & Power LLC-エネルギー分野:企業M&A・提携分析
    Summary Sempra U.S. Gas & Power, LLC (Sempra US), a subsidiary of Sempra Energy, an energy solution provider, is a clean power solutions developer. It develops, designs, constructs and operates renewable energy and natural gas solutions, with a focus on zero and low emission fuels. The company owns …
  • Cytox Ltd-医療機器分野:企業M&A・提携分析
    Summary Cytox Ltd (Cytox) is a diagnostic and prognostic service provider that develops services for neurodegenerative disorders. The company’s blood tests are used to predict, which patients with MCI will develop Alzheimer's disease. Its biomarkers are based on the cell cycle hypothesis of Alzheime …
  • PT Pertamina (Persero):企業の戦略・SWOT・財務分析
    PT Pertamina (Persero) - Strategy, SWOT and Corporate Finance Report Summary PT Pertamina (Persero) - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Monsoon Accessorize Ltd:企業の戦略・SWOT・財務分析
    Monsoon Accessorize Ltd - Strategy, SWOT and Corporate Finance Report Summary Monsoon Accessorize Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • RiskSense Inc:企業の戦略的SWOT分析
    RiskSense Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Minnesota Municipal Power Agency:企業の戦略的SWOT分析
    Minnesota Municipal Power Agency - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pr …
  • Claris Lifesciences Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Claris Lifesciences Ltd (Claris) is a manufacturer of generic drugs and pharmaceutical products. The company provides generic drugs that are directly injected into the human body, which is mainly used in the treatment of critical illnesses. It provides products are offered through various de …
  • Dynavax Technologies Corp (DVAX):企業の財務・戦略的SWOT分析
    Dynavax Technologies Corp (DVAX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • J Uriach Y Compania SA-製薬・医療分野:企業M&A・提携分析
    Summary J Uriach Y Compania SA (Uriach) is a pharmaceutical company that offers food supplements, cosmetics and OTC products. It also researches, develops and manufactures active ingredients for the pharmaceutical market. Uriach provides antiflatulents, antifungals, mineral supplements and antiplate …
  • Clovis Oncology Inc (CLVS):製薬・医療:M&Aディール及び事業提携情報
    Summary Clovis Oncology Inc (Clovis) is a biopharmaceutical company that acquires, develops and commercializes new anti-cancer agents. The company's development programs are targeted at specific cancer indications, combining personalized medicine with companion diagnostics. It develops and commercia …
  • Votorantim Energia Ltda:企業の戦略的SWOT分析
    Votorantim Energia Ltda - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Rockwell Automation Inc (ROK):電力:M&Aディール及び事業提携情報
    Summary Rockwell Automation Inc (Rockwell) is a provider of industrial automation power, control and information systems. The company offers connected components, midrange architecture system, asset and consultancy management; engineered packages and panels integration; front end engineering and des …
  • Cooper Tire & Rubber Company:企業の戦略・SWOT・財務情報
    Cooper Tire & Rubber Company - Strategy, SWOT and Corporate Finance Report Summary Cooper Tire & Rubber Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Koninklijke Ten Cate NV:企業の戦略的SWOT分析
    Koninklijke Ten Cate NV - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Artizian Catering Services Ltd:企業の戦略・SWOT・財務分析
    Artizian Catering Services Ltd - Strategy, SWOT and Corporate Finance Report Summary Artizian Catering Services Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆